Tebbi CK. Etiology of acute leukemia: a review. Cancers. 2021. https://doi.org/10.3390/cancers13092256.

Article  PubMed  PubMed Central  Google Scholar 

Schmidt JA, Hornhardt S, Erdmann F, Sánchez-García I, Fischer U, Schüz J, et al. Risk factors for childhood leukemia: radiation and beyond. Front Public Health. 2021;9: 805757.

Article  PubMed  PubMed Central  Google Scholar 

Shadman M. Diagnosis and treatment of chronic lymphocytic leukemia: a review. JAMA. 2023;329(11):918–32.

Article  PubMed  CAS  Google Scholar 

Clarke Rachel T, Van den Bruel A, Bankhead C, Mitchell CD, Phillips B, Thompson MJ. Clinical presentation of childhood leukaemia: a systematic review and meta-analysis. Arch Dis Childhood. 2016;101(10):894–901.

Article  CAS  Google Scholar 

Inaba H, Pui CH. Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia. J Clin Med. 2021;10(9):1926.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Du M, Chen W, Liu K, Wang L, Hu Y, Mao Y, et al. The global burden of leukemia and its attributable factors in 204 countries and territories: findings from the global burden of disease 2019 study and projections to 2030. J Oncol. 2022;2022:1612702. https://doi.org/10.1155/2022/1612702.

Article  PubMed  PubMed Central  Google Scholar 

Zhao C, Dong H, Xu Q, Zhang Y. Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present). Expert Opin Ther Patents. 2020;30(4):263–74.

Article  CAS  Google Scholar 

Li G, Tian Y, Zhu WG. The roles of histone deacetylases and their inhibitors in cancer therapy. Front Cell Dev Biol. 2020;8: 576946.

Article  PubMed  PubMed Central  Google Scholar 

Parveen R, Harihar D, Chatterji BP. Recent histone deacetylase inhibitors in cancer therapy. Cancer. 2023;129(21):3372–80.

Article  PubMed  CAS  Google Scholar 

Verza FA, Das U, Fachin AL, Dimmock JR, Marins M. Roles of histone deacetylases and inhibitors in anticancer therapy. Cancers. 2020;12(6):1664.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lee HT, Oh S, Yoo H, Kwon YW. The key role of DNA methylation and histone acetylation in epigenetics of atherosclerosis. J Lipid Atheroscl. 2020;9(3):419.

Article  CAS  Google Scholar 

Ruzic D, Djoković N, Srdić-Rajić T, Echeverria C, Nikolic K, Santibanez JF. Targeting histone deacetylases: opportunities for cancer treatment and chemoprevention. Pharmaceutics. 2022. https://doi.org/10.3390/pharmaceutics14010209.

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Seto E. HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb Perspect Med. 2016. https://doi.org/10.1101/cshperspect.a026831.

Article  PubMed  PubMed Central  Google Scholar 

Ocker M. Deacetylase inhibitors—focus on non-histone targets and effects. World J Biol Chem. 2010;1(5):55–61. https://doi.org/10.4331/wjbc.v1.i5.55.

Article  PubMed  PubMed Central  Google Scholar 

San José-Enériz E, Gimenez-Camino N, Agirre X, Prosper F. HDAC inhibitors in acute myeloid leukemia. Cancers. 2019. https://doi.org/10.3390/cancers11111794.

Article  PubMed  PubMed Central  Google Scholar 

Alseksek RK, Ramadan WS, Saleh E, El-Awady R. The role of HDACs in the response of cancer cells to cellular stress and the potential for therapeutic intervention. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23158141.

Article  PubMed  PubMed Central  Google Scholar 

Gong P, Wang Y, Jing Y. Apoptosis induction by histone deacetylase inhibitors in cancer cells: role of Ku70. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20071601.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Zhong Q. Histone deacetylase inhibitors and cell death. Cell Mol Life Sci CMLS. 2014;71(20):3885–901. https://doi.org/10.1007/s00018-014-1656-6.

Article  PubMed  CAS  Google Scholar 

Gammoh N, Lam D, Puente C, Ganley I, Marks PA, Jiang X. Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death. Proc Natl Acad Sci USA. 2012;109(17):6561–5. https://doi.org/10.1073/pnas.1204429109.

Article  PubMed  PubMed Central  Google Scholar 

Ghelli Luserna di Rora A, Iacobucci I, Martinelli G. The cell cycle checkpoint inhibitors in the treatment of leukemias. J Hematol Oncol. 2017;10(1):77. https://doi.org/10.1186/s13045-017-0443-x.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stephen NM, Deepika UR, Maradagi T, Sugawara T, Hirata T, Ganesan P. Insight on the cellular and molecular basis of blood vessel formation: a specific focus on tumor targets and therapy. MedComm Oncol. 2023;2(1): e22. https://doi.org/10.1002/mog2.22.

Article  CAS  Google Scholar 

Ellis L, Hammers H, Pili R. Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett. 2009;280(2):145–53. https://doi.org/10.1016/j.canlet.2008.11.012.

Article  PubMed  CAS  Google Scholar 

Jin G, Bausch D, Knightly T, Liu Z, Li Y, Liu B, et al. Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro. Surgery. 2011;150(3):429–35. https://doi.org/10.1016/j.surg.2011.07.001.

Article  PubMed  Google Scholar 

Kuljaca S, Liu T, Tee AEL, Haber M, Norris MD, Dwarte T, et al. Enhancing the anti-angiogenic action of histone deacetylase inhibitors. Mol Cancer. 2007;6(1):68. https://doi.org/10.1186/1476-4598-6-68.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim HJ, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res. 2011;3(2):166–79.

PubMed  CAS  Google Scholar 

Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 2023;14(9):587. https://doi.org/10.1038/s41419-023-06110-6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Karagiannis D, Rampias T. HDAC inhibitors: dissecting mechanisms of action to counter tumor heterogeneity. Cancers. 2021. https://doi.org/10.3390/cancers13143575.

Article  PubMed  PubMed Central  Google Scholar 

Bose P, Dai Y, Grant S. Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights. Pharmacol Ther. 2014;143(3):323–36. https://doi.org/10.1016/j.pharmthera.2014.04.004.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang B, Lyu J, Yang EJ, Liu Y, Wu C, Pardeshi L, et al. Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells. Acta Pharmaceutica Sinica B. 2020;10(4):615–27. https://doi.org/10.1016/j.apsb.2019.08.008.

Article  PubMed  CAS  Google Scholar 

Mrakovcic M, Bohner L, Hanisch M, Fröhlich LF. Epigenetic targeting of autophagy via HDAC inhibition in tumor cells: role of p53. Int J Mol Sci. 2018. https://doi.org/10.3390/ijms19123952.